English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  50704442    線上人數 :  320
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 		 
搜尋範圍 進階搜尋
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR
計畫說明

瀏覽
典藏機構
作者
題名
日期
統計圖表
機構即時統計
學術趨勢

消息
2019臺灣學術機構典藏
研討會
機構典藏系統RC7版本已
發佈

著作權
出版社及期刊政策查詢
TAIR著作權會議記錄

相關連結
機構典藏計畫網站
ROAR
OpenDOAR
SHERPA
OAIster
JAIRO
Ira
DSPACE
RWWR
臺大學術典藏NTU Scholars
臺灣機構典藏 TAIR >  依作者瀏覽

"| liu c h"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 11-37 / 37 (共1頁)
1 
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-07-12T02:44:45Z Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications Wu H.-L; | Kao J.-H; | Chen T.-C; | Wu W.-H; | Liu C.-H; | Su T.-H; | HUNG-CHIH YANG; | Chen D.-S; | Chen P.-J; | Liu C.-J.
臺大學術典藏 2021-07-12T02:44:43Z Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection Tseng T.-C; | Liu C.-J; | Chen C.-L; | Yang W.-T; | HUNG-CHIH YANG; | Su T.-H; | Wang C.-C; | Kuo S.F.-T; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:43Z Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection Cheng H.-R; | Kao J.-H; | Wu H.-L; | Tseng T.-C; | Liu C.-H; | HUNG-CHIH YANG; | Su T.-H; | Chen P.-J; | Chen D.-S; | Liu C.-J.
臺大學術典藏 2021-07-12T02:44:42Z Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy Liang C.-C; | Liu C.-H; | Chung C.-S; | Lin C.-K; | Su T.-H; | HUNG-CHIH YANG; | Liu C.-J; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:41Z Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers Tseng T.-C; | Liu C.-J; | HUNG-CHIH YANG; | Chen C.-L; | Yang W.-T; | Tsai C.-S; | Kuo S.F.-T; | Verbree F.C; | Su T.-H; | Wang C.-C; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:41Z Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition Su T.-H; | Shiau C.-W; | Jao P; | Liu C.-H; | Liu C.-J; | Tai W.-T; | Jeng Y.-M; | HUNG-CHIH YANG; | Tseng T.-C; | Huang H.-P; | Cheng H.-R; | Chen P.-J; | Chen K.-F; | Kao J.-H; | Chen D.-S.
臺大學術典藏 2021-07-12T02:44:38Z Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection Yang W.-T; | Wu L.-W; | Tseng T.-C; | Chen C.-L; | HUNG-CHIH YANG; | Su T.-H; | Wang C.-C; | Kuo S.F.-T; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Liu C.-J; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:38Z Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study Su T.-H; | Liu C.-J; | Tseng T.-C; | Chou S.-W; | Liu C.-H; | HUNG-CHIH YANG; | Wu S.-J; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:36Z Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma Tseng T.-C; | Liu C.-J; | Su T.-H; | Yang W.-T; | Chen C.-L; | HUNG-CHIH YANG; | Wang C.-C; | Kuo S.F.-T; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:35Z Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis Su T.-H; | Shiau C.-W; | Jao P; | Yang N.-J; | Tai W.-T; | Liu C.-J; | Tseng T.-C; | HUNG-CHIH YANG; | Liu C.-H; | Huang K.-W; | Hu T.-C; | Huang Y.-J; | Wu Y.-M; | Chen L.-J; | Chen P.-J; | Chen D.-S; | Chen K.-F; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:35Z Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients Lee M.-H; | Huang C.-F; | Lai H.-C; | Lin C.-Y; | Dai C.-Y; | Liu C.-J; | Wang J.-H; | Huang J.-F; | Su W.-P; | HUNG-CHIH YANG; | Kee K.-M; | Yeh M.-L; | Chuang P.-H; | Hsu S.-J; | Huang C.-I; | Kao J.-T; | Chen C.-C; | Chen S.-H; | Jeng W.-J; | Yang H.-I; | Yuan Y; | Lu S.-N; | Sheen I.-S; | Liu C.-H; | Peng C.-Y; | Kao J.-H; | Yu M.-L; | Chuang W.-L; | Chen C.-J.
臺大學術典藏 2021-07-12T02:44:33Z Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy Su T.-H; | HUNG-CHIH YANG; | Tseng T.-C; | Liou J.-M; | Liu C.-H; | Chen C.-L; | Chen P.-J; | Chen D.-S; | Liu C.-J; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:32Z Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection Tseng T.-C; | Liu C.-J; | Su T.-H; | Yang W.-T; | Chen C.-L; | HUNG-CHIH YANG; | Kuo S.F.-T; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:31Z Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapy Su T.-H; | Liao C.-H; | Liu C.-H; | Huang K.-W; | Tseng T.-C; | HUNG-CHIH YANG; | Liu C.-J; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:29Z Profile and value of FIB-4 in patients with dual chronic hepatitis C and B Liu C.-J; | Tseng T.-C; | Yang W.-T; | Su T.-H; | HUNG-CHIH YANG; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:29Z Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection Su T.-H; | Liu C.-J; | Tseng T.-C; | Chou S.-W; | Liu C.-H; | HUNG-CHIH YANG; | Wu S.-J; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:28Z Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma Su T.-H; | Liu C.-J; | Tseng T.-C; | Chou S.-W; | Liu C.-H; | HUNG-CHIH YANG; | Wu S.-J; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:26Z Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism Su T.-H; | HUNG-CHIH YANG; | Tseng T.-C; | Chou S.-W; | Lin C.-H; | Liu C.-H; | Liu C.-J; | Chen C.-L; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:26Z NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging Su T.-H; | Liao S.-H; | Hong C.-M; | Liu C.-J; | Tseng T.-C; | Liu C.-H; | HUNG-CHIH YANG; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Adhoute X; | Bourli?re M; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:25Z Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis Su T.-H; | Peng C.-Y; | Tseng T.-C; | HUNG-CHIH YANG; | Liu C.-J; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:25Z High Level of Hepatitis B Core�VRelated Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load Tseng T.-C; | Liu C.-J; | Hsu C.-Y; | Hong C.-M; | Su T.-H; | Yang W.-T; | Chen C.-L; | HUNG-CHIH YANG; | Huang Y.-T; | Fang-Tzu Kuo S; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:24Z HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis Tseng T.-C; | Liu C.-J; | Chang C.T; | Su T.-H; | Yang W.-T; | Tsai C.-H; | Chen C.-L; | HUNG-CHIH YANG; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:24Z Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy Tseng T.-C; | Peng C.-Y; | Hsu Y.-C; | Su T.-H; | Wang C.-C; | Liu C.-J; | HUNG-CHIH YANG; | Yang W.-T; | Lin C.-H; | Yu M.-L; | Lai H.-C; | Tanaka Y; | Nguyen M.H; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:23Z Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data Hong C.-M; | Liu C.-H; | Su T.-H; | HUNG-CHIH YANG; | Chen P.-J; | Chen Y.-W; | Kao J.-H; | Liu C.-J.
臺大學術典藏 2021-07-12T02:44:22Z Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer Su T.-H; | Tseng T.-C; | Liu C.-J; | Chou S.-W; | Liu C.-H; | HUNG-CHIH YANG; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:21Z High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy Chang W.-Y; | Chiu Y.-C; | Chiu F.-W; | Hsu Y.-C; | Tseng T.-C; | Cheng P.-N; | Yang S.-S; | Liu C.-J; | Su T.-H; | HUNG-CHIH YANG; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:19Z Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load Tseng T.-C; | Liu C.-J; | Yang W.-T; | Hsu C.-Y; | Hong C.-M; | Su T.-H; | Tsai C.-H; | Chen C.-L; | HUNG-CHIH YANG; | Liu C.-H; | Chen H.-H; | Chen P.-J; | Kao J.-H.

顯示項目 11-37 / 37 (共1頁)
1 
每頁顯示[10|25|50]項目

DSpace Software Copyright © 2002-2004  MIT   &  Hewlett-Packard   /   Enhanced by   NTU Library IR team